Shenzhen-Hong Kong Cell Valley (Shenzhen) Medical Technology Co., Ltd. is located in Phase II of the Qianhai Shenzhen-Hong Kong Youth Dream Factory in Nanshan District, Shenzhen, covering an area of over 1,100 square meters. The company specializes in the development of new cell and gene therapy (CGT) drugs, high-end medical services, precision medical testing, and the anti-aging health industry.
As one of the key investment projects for the Qianhai Free Trade Zone's 10th anniversary, the company leverages the robust R&D and technological foundation of Shenzhen Cell Valley and the abundant capital and international resources of Hong Kong Cell Valley to advance the development of cell therapy drugs, personalized medical care, and health management services. Its business covers areas such as tumor treatment, autoimmune diseases, degenerative geriatric diseases, and cancer prevention.
Derived from the culture supernatant of mesenchymal stem cells extracted from (animal) umbilical cord, it adopts a multi-step purification process (SEC+ultracentrifugation), nano-scale filtration, and an optimized freeze-drying process to prepare a high-purity, high-activity cell component freeze-dried powder. It has a cosmetics production license registration number.
High-purity, high-activity, high-stability GMP-grade exosomes secreted by mesenchymal stem cells contain bioactive substances such as growth factors, microRNA and anti-inflammatory factors, and have therapeutic effects such as tissue repair, immune regulation, anti-inflammation, and anti-oxidation.
在线咨询：
邮件：laijiaqi@sz-cell.com
工作时间：周一至周五，9:00-18:00，节假日休息
